A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Femme et Homme

| Pays :
Finland
France
Germany
| Organes :
| Spécialités :

Extrait

Definition: Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.

Critère d'inclusion

Urologic Neoplasms

Liens

ictrp
nct